J. D. ELLIOTT

A role for endogenous endothelin-1 in neointimal formation after rat carotid artery balloon angioplasty. Protective effects of the novel nonpeptide endothelin receptor antagonist SB 209670.

S A Douglas, Calvert Louden, Lynne M. Vickery‐Clark et al. · Circulation Research · 1994 · 199 citations · Full text

Medicine, Cardiology, Pharmacology +13

Nonpeptide endothelin receptor antagonists. V: Prevention and reversal of acute renal failure in the rat by SB 209670.

M. Gellai, M Jugus, Tracey Fletcher et al. · Journal of Pharmacology and Experimental Therapeutics · 1995 · 68 citations

Medicine, Pharmacology, Pharmacotherapy +16

The Endothelin Receptor Antagonist SB 217242 Reduces Cerebral Focal Ischemic Brain Injury

Frank C. Barone, Ray F. White, J. D. ELLIOTT et al. · Journal of Cardiovascular Pharmacology · 1995 · 57 citations · Full text

Medicine, Neuroscience, Pharmacology +17

Nonpeptide endothelin receptor antagonists. VI: Pharmacological characterization of SB 217242, a potent and highly bioavailable endothelin receptor antagonist.

Eliot H. Ohlstein, P Nambi, Amparo M. Lago et al. · Journal of Pharmacology and Experimental Therapeutics · 1996 · 55 citations

Medicine, Medicinal Chemistry, Pharmacology +11

Tyr-129 is important to the peptide ligand affinity and selectivity of human endothelin type A receptor.

J A Lee, J. D. ELLIOTT, J Sutiphong et al. · Proceedings of the National Academy of Sciences · 1994 · 48 citations

Medicine, Molecular Biology, Pharmacology +17